Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares
IE00B3WVRB16
Polar Capital Funds plc - Biotechnology Fund Class I EUR Distribution Shares/ IE00B3WVRB16 /
NAV29/08/2024 |
Chg.+0.4500 |
Type de rendement |
Focus sur l'investissement |
Société de fonds |
45.2200EUR |
+1.01% |
reinvestment |
Equity
Worldwide
|
Polar Capital ▶ |
Stratégie d'investissement
The objective of the Fund is to preserve capital and achieve long term capital appreciation by investing worldwide in the shares of biotechnology, diagnostics and life sciences tools companies.
The Fund is broadly diversified across countries, biotechnology sectors and by market-cap (a measure of company size). The Fund may invest in financial derivatives (complex instruments based upon the value of underlying assets) for hedging, to reduce risk, to manage the Fund more efficiently, or to gain exposure to securities in a more efficient way. The Fund is actively managed and uses the NASDAQ Biotechnology Net Total Return Index (EUR) benchmark as a performance target and to calculate the performance fee. The currency of the Fund is US Dollar and the currency of this share class is Euro (EUR). Any income which the Fund generates may be paid out in the form of an annual dividend at the sole discretion of the Directors.
Objectif d'investissement
The objective of the Fund is to preserve capital and achieve long term capital appreciation by investing worldwide in the shares of biotechnology, diagnostics and life sciences tools companies.
Opérations
Type de rendement: |
reinvestment |
Fonds Catégorie: |
Equity |
Région de placement: |
Worldwide |
Branche: |
Sector Biotechnology |
Benchmark: |
NASDAQ Biotechnology Net Total Return Index (EUR) |
Début de l'exercice: |
01/01 |
Dernière distribution: |
- |
Banque dépositaire: |
Northern Trust Fiduciary Serv. (IE) Ltd |
Domicile: |
Ireland |
Permission de distribution: |
Austria, Germany, Switzerland, Czech Republic |
Gestionnaire du fonds: |
David Pinniger |
Actif net: |
- |
Date de lancement: |
31/10/2013 |
Focus de l'investissement: |
- |
Conditions
Surtaxe d'émission: |
5.00% |
Frais d'administration max.: |
1.00% |
Investissement minimum: |
1,000,000.00 EUR |
Deposit fees: |
- |
Frais de rachat: |
0.00% |
Prospectus simplifié: |
Télécharger (Version imprimée) |
Société de fonds
Société de fonds: |
Polar Capital |
Adresse: |
16 Palace Street, SW1E 5JD, London |
Pays: |
United Kingdom |
Internet: |
www.polarcapital.co.uk
|
Actifs
Stocks |
|
99.03% |
Cash |
|
0.21% |
Autres |
|
0.76% |
Pays
United States of America |
|
65.93% |
Netherlands |
|
8.14% |
Denmark |
|
6.29% |
Sweden |
|
5.01% |
Canada |
|
3.24% |
United Kingdom |
|
3.21% |
Belgium |
|
2.94% |
Ireland |
|
1.19% |
France |
|
1.10% |
Bermuda |
|
0.89% |
Germany |
|
0.71% |
Cash |
|
0.21% |
Autres |
|
1.14% |
Branches
Pharma/Biotechnology |
|
97.87% |
Healthcare services |
|
0.67% |
Cash |
|
0.21% |
Gesundheitswesen/ Informationstechnologie |
|
0.11% |
Autres |
|
1.14% |